Details about the neuroanatomical projections from ORBvl to PERI
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91795 | Orbital area ventrolateral part | Perirhinal area | very strong | biotinylated dextran amine (BDA) | this injection gave rise to a dense plexus of labeled terminal axons rostrally in PER at the fundus and the dorsal bank of the rhinal sulcus, involving dorsal area 35 and ventral area 36 (Figs. 5B, 11B). This patch of dense axonal label was located in a restricted rostrocaudal zone (less than 1 mm), where the dorsal hippocampus makes contact with the ventral hippocampus in coronal sections. Collator note: Swanson Atlas Levels 32-33. | Kondo H. & Witter M.P., 2014 | |
| 91797 | Orbital area ventrolateral part | Perirhinal area | light/moderate | biotinylated dextran amine (BDA) | Collator note: rostralmost, PERI is labeled weakly-moderate, mostly in layer VI. See Fig. 5A, Swanson Atlas Level 31. | Kondo H. & Witter M.P., 2014 | |
| 91799 | Orbital area ventrolateral part | Perirhinal area | moderate | biotinylated dextran amine (BDA) | Collator note: clear continuation of the terminal field from ECT, at least in the rostroventral part of the TEA. See Fig 5A, Swanson Atlas Level 31. | Kondo H. & Witter M.P., 2014 | |
| 91800 | Orbital area ventrolateral part | Perirhinal area | light | biotinylated dextran amine (BDA) | Labeling intensity in PER decreased at more caudal levels (Fig. 5C,D) […]. Collator note: few terminals in layers VI and III. See Fig. 5D, Swanson Atlas Levels 40-41. | Kondo H. & Witter M.P., 2014 | |
| 91819 | Orbital area ventrolateral part | Perirhinal area | moderate/strong | biotinylated dextran amine (BDA) | Caudal POR showed moderate to dense labeling of terminating axons (Figs. 6F, 12B), was also the case for the rostral PER, especially around the border between areas 35 and 36 (Fig. 6B). Collator note: moderate-strong terminal field in the dorsal PERI and ventral ECT, in layers II-III. Se Fig. 6B, Swanson Atlas Levels 32-33. | Kondo H. & Witter M.P., 2014 | |
| 91821 | Orbital area ventrolateral part | Perirhinal area | very light | biotinylated dextran amine (BDA) | Labeling in PER decreased at more rostral levels (Fig. 6A) and at more caudal levels (Fig. 6C,D). Collator note: very few labeled fibers in the rostralmost part of the PERI and ECT. See Fig. 6A, Swanson Atlas Levels 30-31. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-17), the BDA injection targeted the lateral portion of VO at a caudal level (Figs. 2, 5). The injection involved mainly layers II and III.Collator note: injection in the caudal third of the ORBvl. See Figs. 1, 2, and 5. The injection is mapped here onto Swanson Atlas Levels 5-6. |
Further details associated to record number 91799:
|
|
|---|
